Man Group PLC Viking Therapeutics, Inc. Transaction History
Man Group PLC
- $36 Billion
- Q3 2024
A detailed history of Man Group PLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 12,919 shares of VKTX stock, worth $420,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,919
Previous 26,739
51.68%
Holding current value
$420,642
Previous $1.42 Million
42.34%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VKTX
# of Institutions
476Shares Held
63.4MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$196 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$152 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$68.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$61 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.5B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...